GlassScriptPhysician profile
Vilma Benavides
NPI 1215768759
$2,219.69
in general payments reported to CMS, 2019-2025
16 companies · $1,988 in 2025
The $1,988 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $231 · 2025: $1,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,219.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $386.96 | 2025 | Ozempic, Rybelsus |
| Abbvie INC. | $311.81 | 2025 | |
| Lilly USA, LLC | $265.20 | 2025 | Zepbound |
| Astrazeneca Pharmaceuticals LP | $247.53 | 2025 | Airsupra, Breztri, Farxiga |
| Si-Bone, INC. | $191.60 | 2025 | |
| Inspire Medical Systems, INC. | $149.92 | 2024 | Inspire |
| Axsome Therapeutics, INC. | $124.36 | 2025 | Auvelity |
| Kyowa Kirin, INC. | $120.56 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $114.14 | 2025 | Austedo Xr |
| Pfizer INC. | $102.63 | 2024-2025 | |
| Cvrx, INC. | $88.53 | 2025 | Barostim Neo System |
| Exact Sciences Corporation | $41.35 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Organon LLC | $21.09 | 2025 | Nexplanon |
| Amgen INC. | $19.84 | 2025 | Repatha |
| Astellas Pharma US INC | $18.94 | 2025 | Veozah |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $15.23 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vilma Benavides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.